Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market
Sandoz ends its collaboration with the secret CMO that made the contaminated antibiotic product and cannot rule out other drugs could be infected with multi-resistant bacteria.
by ulrich quistgaard, translated by daniel pedersen
The case concerning the contaminated antibiotic Dicillin that infected Danish and Icelandic patients with multi-resistant CPO bacteria has brought a partnership between Sandoz and its contracted manufacturing organization to an end.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
